Chief Business Officer
With more than 25 years of strategy, business / corporate development, alliance management and finance experience in biotech and big-pharma, Ed Koval’s career has focused on the creation of new companies and the strengthening of platforms and pipelines of established ones through financings and strategic partnering deals.
After helping drive the major transactions that led to the founding of ZebiAI, Ed joined the company in June 2020. Prior to that Ed held senior roles at X-Chem, Novartis, Chiron, Merck, Veloxis and various other biotech companies.
Ed holds B.S. and M.S. degrees in engineering from NYU and RPI as well as an M.B.A from the MIT Sloan School of Management.